Advanced multiplicity adjustment methods in clinical trials

被引:70
作者
Alosh, Mohamed [1 ]
Bretz, Frank [2 ,3 ]
Huque, Mohammad [4 ]
机构
[1] US FDA, Div Biometr 3, Off Biostat, OTS,CDER, Silver Spring, MD 20993 USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] Hannover Med Sch, Hannover, Germany
[4] US FDA, Off Biostat, OTS, CDER, Silver Spring, MD USA
关键词
multiple testing; -propagation; adaptive alpha; gatekeeping; graphical methods; CLOSED-TESTING PROCEDURES; FIXED-SEQUENCE; END-POINTS; BONFERRONI PROCEDURE; CONFIDENCE-REGIONS; DOSE-RESPONSE; STRATEGY; MULTISTAGE; SUBGROUP; FALLBACK;
D O I
10.1002/sim.5974
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
During the last decade, many novel approaches for addressing multiplicity problems arising in clinical trials have been introduced in the literature. These approaches provide great flexibility in addressing given clinical trial objectives and yet maintain strong control of the familywise error rate. In this tutorial article, we review multiple testing strategies that are related to the following: (a) recycling local significance levels to test hierarchically ordered hypotheses; (b) adapting the significance level for testing a hypothesis to the findings of testing previous hypotheses within a given test sequence, also in view of certain consistency requirements; (c) grouping hypotheses into hierarchical families of hypotheses along with recycling the significance level between those families; and (d) graphical methods that permit repeated recycling of the significance level. These four different methodologies are related to each other, and we point out some connections as we describe and illustrate them. By contrasting the main features of these approaches, our objective is to help practicing statisticians to select an appropriate method for their applications. In this regard, we discuss how to apply some of these strategies to clinical trial settings and provide algorithms to calculate critical values and adjusted p-values for their use in practice. The methods are illustrated with several numerical examples. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:693 / 713
页数:21
相关论文
共 68 条
[1]
Alosh M, 2007, P JOINT STAT M BIOPH, P198
[2]
Multiplicity considerations for subgroup analysis subject to consistency constraint [J].
Alosh, Mohamed ;
Huque, Mohammad F. .
BIOMETRICAL JOURNAL, 2013, 55 (03) :444-462
[3]
A consistency-adjusted alpha-adaptive strategy for sequential testing [J].
Alosh, Mohamed ;
Huque, Mohammad F. .
STATISTICS IN MEDICINE, 2010, 29 (15) :1559-1571
[4]
A flexible strategy for testing subgroups and overall population [J].
Alosh, Mohamed ;
Huque, Mohammad F. .
STATISTICS IN MEDICINE, 2009, 28 (01) :3-23
[5]
[Anonymous], 1995, Biometrie in der Chemisch-Pharmazeutischen Industrie
[6]
[Anonymous], 2003, MULTIPLE ANAL CLIN T
[7]
[Anonymous], 1987, Multiple comparison procedures
[8]
MULTIPLE TESTING IN CLINICAL-TRIALS [J].
BAUER, P .
STATISTICS IN MEDICINE, 1991, 10 (06) :871-890
[9]
Bauer P, 1998, STAT MED, V17, P2133, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO
[10]
2-2